Dr. Jiayu Wang: Revisiting International Conferences with Promising Efficacy Data – Domestic Innovative CDK4/6 Inhibitor Birociclib as a New Choice for HR+/HER2-MBC Treatment
Editor's Note: During the 2023 European Society for Medical Oncology (ESMO) Annual Meeting, a Phase II multi-center clinical trial's results, led by Academician Xu Binghe and his team from the…